Alan Pestronk
Expertise in
21
conditions

Dr. Alan Pestronk

Neurology
660 S Euclid Ave, Box 8111, 
St. Louis, MO 
Expertise in
21
conditions
660 S Euclid Ave, Box 8111, 
St. Louis, MO 

Overview

Alan Pestronk is a Neurologist practicing medicine in St. Louis, MO.

Dr. Pestronk is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Dysferlinopathy, Miyoshi Myopathy, Pompe Disease, and Myasthenia Gravis.

He is actively involved in clinical research, co-authoring 140 peer reviewed articles and participating in 5 clinical trials.

Residency

Johns Hopkins School of Medicine

Specialties

Neurology

Licenses

Psychiatry & Neurology in MO

Hospital Affiliations

Alton Memorial Hospital
Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Memorial Hospital
Missouri Baptist Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Washington University - Neuromuscular Disease Center
660 S Euclid Ave, Box 8111, St. Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease
A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease
Enrollment Status: Completed
Publish Date: April 13, 2026
Intervention Type: Genetic
Study Drug: AAV2/8LSPhGAA
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Other, Drug
Study Drug: N-Acetylmannosamine
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Types 1 and X
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Types 1 and X
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Enrollment Status: Terminated
Publish Date: June 14, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

140 Total Publications

Identification of prognostic biomarkers in a large cohort of patients with LGMD R2.
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2.
Journal: Journal of neurology
Published: March 10, 2026
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-454-6120
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Gutmann is a Neurologist practicing medicine in Saint Louis, Missouri. Dr. Gutmann is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Optic Glioma, Neurofibromatosis Type 1 (NF1), and Glioma. Dr. Gutmann is currently accepting new patients.

Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

St. Louis Children's Hospital

1 Childrens Pl, 
Saint Louis, MO 
 (0.2 miles away)
314-454-6120
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Renee Shellhaas is a Neurologist practicing medicine in Saint Louis, Missouri. Dr. Shellhaas is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Epilepsy in Children, West Syndrome, Spasmus Nutans, and Seizures. Dr. Shellhaas is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Washington University School Of Medicine

4921 Parkview Pl, 
Saint Louis, MO 
 (0.2 miles away)
314-747-1171
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Milan Chheda is a Neurologist practicing medicine in Saint Louis, Missouri. Dr. Chheda is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Chheda is currently accepting new patients.

Frequently Asked Questions about Dr. Alan Pestronk

How do I make an appointment with Dr. Alan Pestronk?

You can book an appointment with Dr. Alan Pestronk by calling their office at 314-362-6981. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alan Pestronk a top-rated expert for Dysferlinopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alan Pestronk is classified as an Distinguished expert for Dysferlinopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alan Pestronk specialize in?

While Dr. Alan Pestronk is a Neurology, they have specific expertise in Dysferlinopathy, Miyoshi Myopathy, and Pompe Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Alan Pestronk participate in research or clinical trials?

Yes. Dr. Alan Pestronk has published 140 articles and abstracts on conditions like Dysferlinopathy. You can view a list of Dr. Alan Pestronk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alan Pestronk accept my insurance?

Dr. Alan Pestronk accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-6981 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pestronk's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 9 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile